Lv3
289 积分 2023-03-30 加入
Immunotherapy in Gastric Cancer—Choosing Methods or Results
9天前
已关闭
Claudin 18.2 as a novel therapeutic target
12天前
已完结
Durvalumab versus placebo with chemoradiotherapy for locally advanced cervical cancer (CALLA): a randomised, double-blind, phase 3 trial
13天前
已完结
Implications of IL-21 in solid tumor therapy
19天前
已完结
Mocetinostat in Combination With Durvalumab for Patients With Advanced NSCLC: Results From a Phase I/II Study
29天前
已完结
Clinical and immune correlate results from a phase 1b study of the histone deacetylase inhibitor mocetinostat with ipilimumab and nivolumab in unresectable stage III/IV melanoma
29天前
已完结
Entinostat, nivolumab and ipilimumab for women with advanced HER2-negative breast cancer: a phase Ib trial
1个月前
已完结
Therapeutic landscape and future direction of metastatic colorectal cancer
1个月前
已完结
How to overcome resistance to immune checkpoint inhibitors in colorectal cancer: From mechanisms to translation
1个月前
已完结
Current status and prospect of immunotherapy for colorectal cancer
1个月前
已完结
皖公网安备34019202002308
